Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2025 Earnings Call Transcript

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2025 Earnings Call Transcript October 31, 2024

Takeda Pharmaceutical Company Limited beats earnings expectations. Reported EPS is $0.44, expectations were $0.39.

Christopher O’Reilly: Thank you for taking time out of your very busy schedule to join the FY ‘24 Q2 earnings announcement by Takeda. I’m the master of ceremony, Head of IR. My name is O’Reilly. Thank you for this opportunity. [Operator Instructions] Let me start, I’d...